Herbal Monograph
Fenugreek
Trigonella foenum-graecum L.
Fabaceae (Leguminosae)
Warming demulcent seed for blood sugar management, appetite stimulation, lact...
Overview
Plant Description
Annual herbaceous plant, 30-60 cm tall, with an erect, hollow, branching stem that is slightly pubescent. Leaves are trifoliate (clover-like), alternate, with obovate to oblong-lanceolate leaflets 2-5 cm long, serrate at the apex. Stipules are small and triangular. Flowers are sessile or shortly pedicellate, borne singly or in pairs in the leaf axils; corolla is papilionaceous (pea-like), pale yellowish-white, occasionally with a violet base, approximately 1.5 cm long. The fruit is a narrow, elongated, beaked pod (legume), 7-15 cm long, slightly curved like a sickle, containing 10-20 seeds per pod. Seeds are small (3-5 mm), hard, rhomboid to oblong, deeply furrowed with a groove running diagonally across each face, brownish-yellow to amber in color. The entire plant has a strong, characteristic odor due to sotolone (3-hydroxy-4,5-dimethyl-2(5H)-furanone), which intensifies on drying and is reminiscent of maple syrup, caramel, or burnt sugar. The genus name Trigonella refers to the triangular shape of the small flowers.
Habitat
Prefers full sun and well-drained, loamy to sandy soils with a pH of 6.0-7.0. Tolerates poor and semi-arid conditions. Moderately drought-tolerant once established. As a nitrogen-fixing legume (via Rhizobium symbiosis), it improves soil fertility and is used as a green manure and rotation crop. Grows best in temperate to subtropical climates with warm, dry conditions during seed maturation.
Distribution
Native to the eastern Mediterranean region and western Asia (likely originating in the area spanning modern-day Turkey, Iraq, and Iran). One of the oldest cultivated plants, with archaeological evidence from the Bronze Age. Widely cultivated across the Indian subcontinent, North Africa (especially Egypt and Morocco), the Middle East, China, Ethiopia, and southern Europe. Naturalized in many temperate and subtropical regions worldwide. India is the largest global producer, with Rajasthan accounting for the majority of production.
Parts Used
Seed (Trigonellae foenugraeci semen)
Preferred: Crushed or ground seed for decoction and internal use; powdered seed for poultice; whole seed soaked in water overnight; standardized extract (capsule/tablet) for clinical applications
The mature, dried seed is the primary medicinal part and the subject of all major pharmacopeial monographs (Commission E, WHO, EMA, BHP). Seeds contain the highest concentration of steroidal saponins (diosgenin glycosides), galactomannan fiber, 4-hydroxyisoleucine, and trigonelline. The hard seed coat must be crushed, ground, or soaked to release the mucilaginous galactomannan and allow extraction of active constituents. Defatted seed powder has been used in most clinical trials investigating hypoglycemic effects. The seed is official in the European Pharmacopoeia as Trigonellae foenugraeci semen.
Leaf (Trigonellae foenugraeci folium)
Preferred: Fresh leaf as vegetable; dried leaf for culinary use
Fresh leaves are used as a culinary green vegetable (methi saag) in Indian cuisine and have minor traditional medicinal use in Ayurvedic practice for digestive complaints and as a nutritive tonic. Leaves contain lower concentrations of steroidal saponins compared to seeds. Not included in any major Western pharmacopeial monograph. Dried leaves (kasuri methi) are primarily a culinary product.
Key Constituents
Steroidal saponins and sapogenins
The steroidal saponin fraction is one of the two principal classes responsible for fenugreek's hypoglycemic and hypolipidemic effects. Saponins reduce cholesterol absorption in the gut by forming insoluble complexes with cholesterol and bile acids, increase fecal bile acid excretion (promoting hepatic conversion of cholesterol to bile acids), and may modulate insulin secretion via direct effects on pancreatic beta cells. Diosgenin glycosides also inhibit alpha-glucosidase, slowing carbohydrate digestion. The WHO monograph and EMA assessment report identify steroidal saponins as key constituents relevant to the claimed therapeutic effects.
Galactomannan (mucilaginous polysaccharide fiber)
The galactomannan fiber is the primary contributor to fenugreek's effects on postprandial glucose levels through viscous gel formation in the gut, which delays gastric emptying, slows glucose absorption from the small intestine, and reduces postprandial glycemic spikes. Also contributes to satiety (appetite reduction) via gastric distension and delayed emptying. The demulcent and laxative (bulk-forming) properties of fenugreek seed are attributable to this fraction. The gel also entraps bile acids, contributing to the hypolipidemic effect. Commission E and WHO recognize the fiber content as therapeutically relevant.
Amino acids
4-Hydroxyisoleucine is considered a major contributor to the hypoglycemic activity of fenugreek distinct from the fiber and saponin fractions. Its glucose-dependent insulinotropic mechanism has been demonstrated in isolated rat islets, perfused rat pancreas, and in vivo animal models. It acts on pancreatic beta cells to potentiate insulin release without affecting basal insulin secretion at normal glucose levels. This amino acid is a key marker compound for standardized fenugreek extracts targeting glycemic control.
Alkaloids
Trigonelline contributes to the overall hypoglycemic effect of whole fenugreek seed, though its relative contribution is considered secondary to the galactomannan fiber, saponins, and 4-hydroxyisoleucine. Choline supports hepatic lipid metabolism and may contribute to the hypolipidemic effect.
Flavonoids
The flavonoid fraction contributes antioxidant and anti-inflammatory activity. These effects are considered ancillary to the primary hypoglycemic and hypolipidemic actions but may play a supporting role in reducing oxidative stress associated with diabetes and metabolic syndrome.
Volatile compounds
Sotolone is not a therapeutic constituent but is clinically significant because its excretion in body fluids after fenugreek ingestion can mimic the characteristic odor of maple syrup urine disease (MSUD), potentially leading to unnecessary diagnostic concern. Clinicians should be aware of this association when evaluating patients with unexplained maple syrup body odor.
Other constituents
The high protein and mineral content contributes to fenugreek's traditional use as a nutritive tonic, particularly in postpartum recovery and convalescence. The coumarin content, though minor, is relevant to the documented interaction with warfarin and other anticoagulant medications.
Herbal Actions
Fenugreek's most clinically investigated and best-supported action. Multiple mechanisms contribute: galactomannan fiber delays gastric emptying and slows intestinal glucose absorption; 4-hydroxyisoleucine stimulates glucose-dependent insulin secretion from pancreatic beta cells; steroidal saponins inhibit alpha-glucosidase and intestinal glucose transport; trigonelline has additional mild hypoglycemic activity. The net effect is reduction of both fasting blood glucose and postprandial glucose levels. Commission E approved internally for loss of appetite (which relates to the bitter and fiber content), and the WHO monograph discusses adjuvant use in diabetes management. Multiple systematic reviews and meta-analyses of RCTs support clinically meaningful reductions in fasting glucose and HbA1c.
[2, 3, 11, 12]Reduces total cholesterol, LDL cholesterol, and triglycerides through multiple mechanisms: steroidal saponins form insoluble complexes with cholesterol and bile acids in the gut, reducing cholesterol absorption; galactomannan fiber entraps bile acids, promoting hepatic conversion of cholesterol to bile acids; overall effect is increased fecal bile acid and cholesterol excretion. Clinical trials have demonstrated significant reductions in total cholesterol, LDL-C, and triglycerides in diabetic and hyperlipidemic subjects.
[2, 9, 18]Promotes breast milk production
One of the most widely used herbal galactagogues worldwide. Used traditionally across multiple cultures (Ayurvedic, Unani, Middle Eastern, Western herbal) to promote breast milk production. The mechanism is not fully elucidated; proposed mechanisms include: stimulation of sweat gland activity (breasts being modified apocrine glands), phytoestrogenic effects of diosgenin, and general nutritive/tonic action. A network meta-analysis (Foong et al., 2020) concluded that fenugreek was effective in increasing breast milk volume compared to placebo. However, the Academy of Breastfeeding Medicine Protocol #9 notes that evidence for galactagogues generally remains limited in quality.
[4, 14, 26]Soothes and protects irritated mucous membranes
The high galactomannan content (25-45% of seed weight) forms a viscous mucilaginous gel when the crushed or ground seed is mixed with water. This gel coats and soothes inflamed mucosal surfaces of the gastrointestinal tract. The demulcent action is the basis for traditional use in gastritis, peptic ulceration, and inflammatory bowel conditions. Also contributes bulk-forming laxative effects.
[4, 5]Commission E approved indication: 'loss of appetite.' The bitter constituents (steroidal saponins, trigonelline) stimulate gustatory and gastrointestinal reflexes that promote appetite. The EMA monograph recognizes traditional use for temporary loss of appetite. Documented in European phytotherapy at least since 1908.
[1, 3]Commission E approved for external use: 'local inflammation' as a poultice. The mucilaginous seed paste applied topically soothes inflamed tissue, and saponins and flavonoids contribute anti-inflammatory effects. Traditional use as a poultice for boils, abscesses, cellulitis, and inflamed wounds.
[1, 2]Stimulates or increases menstrual flow
Traditional use in Ayurvedic, Unani, and Middle Eastern medicine for promoting menstrual flow and relieving dysmenorrhea. The steroidal saponins (diosgenin) may exert mild estrogenic or uterotonic effects. This action is the basis for the AHPA Class 2b contraindication in pregnancy. Clinical evidence for emmenagogue activity is limited to traditional reports.
[6, 7]Promotes the discharge of mucus from the respiratory tract
Traditional use for productive cough and bronchitis, particularly in Ayurvedic and Unani medicine. The mucilaginous fiber soothes irritated respiratory mucosa while the saponin content may stimulate secretion of thin respiratory mucus. Clinical evidence is limited to traditional use reports.
[4]Therapeutic Indications
metabolic-endocrine
Type 2 diabetes mellitus (adjunctive management)
Multiple RCTs and several systematic reviews/meta-analyses support fenugreek seed (typically 5-50 g/day of seed or defatted seed powder, or standardized extracts) as adjunctive therapy for glycemic control in type 2 diabetes. Neelakantan et al. (2014) meta-analysis of 10 RCTs found significant reductions in fasting blood glucose (FBG) and HbA1c. Gong et al. (2016) meta-analysis confirmed reductions in FBG (WMD -17.11 mg/dL) and HbA1c. However, study quality was generally moderate to low, sample sizes were small, and results were heterogeneous. Fenugreek should be used as a complementary approach alongside conventional diabetes management, not as a replacement.
[2, 9, 10, 11, 12]Hyperlipidemia (mild to moderate, adjunctive)
Clinical trials in diabetic and non-diabetic subjects have shown significant reductions in total cholesterol, LDL-C, and triglycerides with fenugreek supplementation. Sharma et al. (1990) demonstrated significant reductions in total cholesterol, LDL, VLDL, and triglycerides in type 1 diabetic patients receiving 100 g defatted seed powder daily. Sowmya & Rajyalakshmi (1999) showed significant cholesterol reduction in hypercholesterolemic subjects. The WHO monograph notes use as adjunct to a low-fat diet for mild to moderate hypercholesterolemia. Effect sizes vary considerably across studies, and optimal dosing is not standardized.
[2, 9, 18]Prediabetes and metabolic syndrome (risk reduction)
Gaddam et al. (2015) conducted a 3-year RCT of 66 prediabetic subjects and found that fenugreek powder (10 g/day in hot water before meals) significantly reduced the rate of progression to diabetes compared to control. The fenugreek group also showed improvements in fasting glucose and postprandial glucose. However, this is a single study and requires replication.
[13]Digestive System
Loss of appetite (anorexia)
Commission E approved indication for internal use. The bitter steroidal saponins and alkaloids stimulate gustatory and gastrointestinal reflexes that promote appetite and digestive secretion. The EMA monograph recognizes traditional use for temporary loss of appetite at a daily dose of 6 g of crushed seed. Documented use as an appetite stimulant in Indian Materia Medica since at least 1908.
[1, 2, 3]Dyspepsia and gastric inflammation
The combination of demulcent (mucilaginous), bitter, and anti-inflammatory properties provides pharmacological rationale for use in gastritis and functional dyspepsia. The mucilaginous galactomannan coats and protects inflamed gastric mucosa while bitter constituents stimulate digestive secretion. Traditional use documented in Ayurvedic, Unani, and Western herbal practice.
[4, 5]Constipation (mild, functional)
The high soluble fiber content (galactomannan, 25-45%) acts as a bulk-forming laxative, absorbing water and increasing stool volume. This promotes peristalsis and regular bowel movements. Fenugreek is classified as a bulk-forming laxative in several pharmacopeial references.
[2, 4]reproductive-womens-health
Insufficient lactation (galactagogue support)
One of the most widely used herbal galactagogues globally. Turkyilmaz et al. (2011) RCT found that fenugreek herbal tea significantly increased breast milk production compared to placebo in the first days postpartum. Foong et al. (2020) network meta-analysis found fenugreek effective for increasing breast milk volume. However, the ABM Protocol #9 (2018) notes that evidence for all galactagogues remains limited in quality and recommends first addressing modifiable factors (latch, feeding frequency). LactMed notes fenugreek use is widespread but advises caution regarding adverse effects.
[14, 15, 26]Dysmenorrhea and menstrual irregularity
Traditional use in Ayurvedic and Unani medicine for painful and irregular menstruation. The steroidal saponins (diosgenin) may exert weak estrogenic or uterotonic effects. Younesy et al. (2014) conducted a double-blind RCT in 101 women with primary dysmenorrhea and found that fenugreek seed powder (2,500 mg/day for 2 menstrual cycles) significantly reduced pain severity compared to placebo. However, this is a single study requiring replication.
[7, 17]Skin / Integumentary
Local inflammation, boils, abscesses (external — poultice)
Commission E approved external use for 'local inflammation.' Crushed fenugreek seed is mixed with hot water to form a warm poultice (cataplasm) applied to boils, abscesses, cellulitis, ulcers, and inflamed wounds. The mucilaginous paste draws, soothes, and reduces local inflammation. Dose: 50 g powdered seed in 250 mL hot water, applied as a warm poultice. Traditional use for skin inflammation documented across multiple traditions.
[1, 2, 3]Respiratory System
Productive cough and bronchitis
Traditional use in Ayurvedic and Unani medicine for productive cough, bronchitis, and chronic respiratory catarrh. The mucilaginous fiber soothes irritated respiratory mucosa while the saponin content may facilitate expectoration. Clinical evidence is limited to traditional reports and pharmacological rationale.
[4]Energetics
Temperature
warm
Moisture
moist
Taste
Tissue States
cold/depression, dry/atrophy, wind/tension
Fenugreek is warming and moistening in Western energetic assessment. Its pronounced bitterness stimulates digestive secretions and appetite; the pungency provides circulatory stimulation and warming quality; and the underlying sweetness reflects the mucilaginous, nutritive, tissue-building nature of the seed. The combination of warming and moistening properties is relatively uncommon and makes fenugreek particularly well-suited for cold, dry, depleted tissue states — the typical presentation of chronic debility, convalescence, wasting, and postpartum depletion. In Ayurvedic terms, fenugreek reduces Vata (cold, dry, nervous) and Kapha (cold, damp, congestive) doshas but may aggravate Pitta (hot, inflammatory) in excess due to its warming quality. Hoffmann describes fenugreek as combining demulcent and bitter tonic properties in a warming, nutritive package.
Traditional Uses
Ayurvedic medicine
- Treatment of Vata disorders: neuralgia, paralysis, rheumatism, sciatica
- Digestive support: loss of appetite, dyspepsia, abdominal distension, constipation
- Kapha disorders: productive cough, bronchitis, asthma with copious phlegm
- Postpartum tonic and galactagogue to promote breast milk production
- Diabetes management (Prameha — urinary disorders with sweetness)
- Nutritive tonic for debility, convalescence, and emaciation
- Emmenagogue for delayed or painful menstruation
"In Ayurveda, fenugreek (Methi) is classified as having bitter (Tikta), pungent (Katu), and sweet (Madhura) tastes with warming energy (Ushna Virya) and sweet post-digestive effect (Madhura Vipaka). It reduces Vata and Kapha doshas. The Bhavaprakasha Nighantu describes fenugreek as useful in disorders of Vata dosha imbalance such as neuralgia, paralysis, constipation, and bloating, and in Kapha conditions including productive cough, asthma, and bronchitis. It is used as a digestive stimulant, galactagogue, and uterine tonic."
[23]
Unani (Greco-Arab) medicine
- Mundij (concoctive) — aids in maturation and resolution of morbid humors
- Muhallil-i-Waram — resolves inflammation and swelling
- Treatment of hemiplegia, facial palsy, and backache
- Disorders of liver and spleen, including splenitis and hepatomegaly
- Ascites and old (chronic) cough
- Poultice for swellings, boils, and burning sensation
- Galactagogue and uterine tonic
"In Unani medicine, fenugreek (Hulba) is described as Hot and Dry in the second degree (Har wa Yabis fi al-Darajat al-Thaniyah). Both seeds and leaves are used. The seeds are considered Mundij (concoctive), helping to ripen and resolve morbid humors, and Muhallil-i-Waram (anti-inflammatory). They are used to treat hemiplegia, facial palsy, backache, splenitis, and chronic cough. External application is recommended for swellings and local inflammation."
[24]
Ancient Egyptian medicine
- Treatment of fever (antipyretic)
- Incense and embalming material
- Used in childbirth to ease labor
- Consumed as a vegetable and food staple
"Fenugreek is documented in the Ebers Papyrus (c. 1550 BCE), one of the oldest surviving medical texts. In ancient Egypt, fenugreek seeds were used to combat fever, consumed as a vegetable, employed in incense, and incorporated into the process of embalming mummies. Fenugreek was also used to ease childbirth."
[21]
Greco-Roman medicine
- Softening and resolving swellings and inflammations (poultice)
- Treatment of gynecological conditions and uterine complaints
- Cattle fodder and agricultural use
"Dioscorides (De Materia Medica, 1st century CE) describes fenugreek under the name 'Telis' or 'Bouceras' (ox-horn, referring to the curved pods). He recommends a decoction of the seed for gynecological conditions and a poultice of the ground seed mixed with vinegar or wine for softening and resolving swellings and inflammations. The Latin name 'foenum-graecum' means 'Greek hay,' reflecting its widespread cultivation in the Greco-Roman world as both fodder and medicine."
[22]
German phytotherapy (Commission E)
- Internal: Loss of appetite
- External: Local inflammation (poultice)
"Commission E approved two indications for fenugreek seed: internally for loss of appetite, and externally as a poultice for local inflammation. Internal dose: 6 g of seed daily. External dose: 50 g powdered seed in 250 mL hot water as a warm cataplasm."
[1]
European traditional herbalism (Western)
- Convalescent and nutritive tonic for debility and weight loss
- Demulcent for gastric and intestinal inflammation
- Galactagogue in breastfeeding mothers
- Poultice for boils, abscesses, and inflamed wounds
- Mild laxative (bulk-forming fiber)
"Hoffmann (2003) describes fenugreek as 'a warming and nutritive herb combining demulcent, bitter, and tonic properties. It is used as a digestive tonic for loss of appetite and dyspepsia, as a demulcent for gastric inflammation, as a nutritive tonic in convalescence and debility, and as a galactagogue to promote breast milk production.' The BHP (1983) lists fenugreek as a tonic with demulcent and hypoglycemic actions."
Modern Research
Glycemic control in type 2 diabetes (meta-analysis)
Systematic review and meta-analysis of randomized controlled trials evaluating fenugreek's effect on glycemic parameters in type 2 diabetes and prediabetes.
Findings: Neelakantan et al. (2014) conducted a systematic review and meta-analysis of 10 clinical trials evaluating fenugreek seed preparations (doses ranging from 1 g to 100 g/day, durations from 10 days to 3 years). The pooled analysis found significant reductions in fasting blood glucose (WMD -0.96 mmol/L, 95% CI -1.52 to -0.40, P=0.001), 2-hour postprandial glucose, and HbA1c (-0.85%, P<0.05) compared to control groups. Subgroup analysis suggested medium-dose regimens (5-50 g/day) were effective, with no clear dose-response relationship at higher doses.
Limitations: Significant heterogeneity across studies in dose, preparation type, duration, and population. Most individual trials had small sample sizes (n < 60). Study quality was generally moderate to low. Publication bias could not be excluded. The authors concluded that larger, well-designed RCTs are needed to confirm optimal dosing and long-term efficacy.
[11]
Fasting blood glucose and HbA1c reduction (meta-analysis)
Meta-analysis examining the effect of fenugreek intake on glycemia across clinical trials in diabetic subjects.
Findings: Gong et al. (2016) conducted a meta-analysis of clinical trials (including 8 RCTs) evaluating fenugreek for hyperglycemia. They found that fenugreek significantly reduced fasting blood glucose (WMD -17.11 mg/dL, P<0.001) and HbA1c (WMD -0.85%) in diabetic subjects. Interestingly, subgroup analysis suggested that lower fenugreek doses (<10 g/day) appeared to produce greater reductions in both FBG and HbA1c compared to higher doses (greater than or equal to 10 g/day), though this may reflect differences in study populations and preparation types.
Limitations: Significant between-study heterogeneity (I-squared > 75%). Overall quality of included studies was rated as poor to moderate. Small sample sizes in most studies. The counterintuitive dose-response finding may reflect confounding rather than a true inverse dose-response relationship.
[12]
Fenugreek in type 1 diabetes — effects on blood glucose and serum lipids
Controlled clinical trial evaluating the effect of defatted fenugreek seed powder on blood glucose and serum lipids in type 1 diabetic patients.
Findings: Sharma, Raghuram & Rao (1990) conducted a crossover trial in 10 type 1 diabetic patients comparing isocaloric diets with and without 100 g/day of defatted fenugreek seed powder for 10 days each. The fenugreek diet significantly reduced fasting blood sugar, improved glucose tolerance (as measured by area under the curve), and reduced 24-hour urinary glucose excretion by 54%. Total cholesterol decreased by 14%, LDL-C by 16%, VLDL-C by 17%, and triglycerides by 15%. HDL-C was unaffected.
Limitations: Very small sample size (n=10). Short duration (10 days). Crossover design without washout period clearly described. Very high dose (100 g/day of defatted powder) unlikely to be practical in real-world use. Type 1 (not type 2) diabetic subjects.
[9]
Galactagogue effect (network meta-analysis)
Network meta-analysis evaluating the effectiveness of fenugreek as a galactagogue compared to other interventions.
Findings: Foong et al. (2020) conducted a network meta-analysis of galactagogue interventions and found that fenugreek was effective in increasing breast milk volume compared to placebo. The analysis ranked fenugreek among the more effective herbal galactagogues. However, the effect size and clinical meaningfulness of the increase varied across studies.
Limitations: Heterogeneity in study designs, populations, doses, and outcome measures across the included trials. Most individual RCTs were small and of moderate quality. Blinding was not always adequate given fenugreek's characteristic odor. The clinical significance of increased breast milk volume (as measured by pumping or test-weighing) may not translate directly to improved infant outcomes.
[14]
Breast milk production — early postpartum RCT
Randomized controlled trial evaluating fenugreek herbal tea on breast milk production and prolactin levels in the early postpartum period.
Findings: Turkyilmaz et al. (2011) randomized 66 mothers to fenugreek herbal tea, placebo tea, or no intervention. Breast milk volume (measured by pumping) was significantly higher in the fenugreek group at day 3 compared to placebo and control groups. Infant weight regain was also faster in the fenugreek group. However, the effect was most apparent in the early lactation period and did not persist at later time points. Serum prolactin levels did not differ significantly between groups.
Limitations: Small sample size (n=22 per group). Short follow-up period. Used breast milk volume obtained by pumping as a surrogate, which may not reflect actual milk intake by the infant. The fenugreek tea also contained other ingredients. Blinding was partial due to the distinctive taste of fenugreek.
[15]
Prediabetes prevention (long-term RCT)
Three-year randomized controlled trial evaluating fenugreek seed powder for prevention of type 2 diabetes in prediabetic individuals.
Findings: Gaddam et al. (2015) randomized 66 individuals with prediabetes to fenugreek seed powder (10 g/day in hot water before meals) or standard lifestyle advice alone for 3 years. The fenugreek group showed significantly lower rates of conversion to type 2 diabetes compared to the control group. Fasting glucose and postprandial glucose were significantly lower in the fenugreek group at 3 years. Insulin resistance (HOMA-IR) also improved.
Limitations: Single-center study with relatively small sample size (n=66). Open-label design (no placebo blinding). The control group received standard lifestyle advice only, not a placebo. Results require confirmation in larger, multicenter, placebo-controlled trials.
[13]
4-Hydroxyisoleucine mechanism of action
Preclinical investigation of the insulinotropic amino acid 4-hydroxyisoleucine isolated from fenugreek seeds.
Findings: Sauvaire et al. (1998) isolated 4-hydroxyisoleucine from fenugreek seeds and demonstrated that it stimulates insulin secretion from isolated rat pancreatic islets in a glucose-dependent manner — meaning insulin release was potentiated only in the presence of elevated glucose concentrations (6.6-16.7 mM) and not at basal glucose levels (3 mM). The compound also enhanced insulin secretion in perfused rat pancreas. This glucose-dependent mechanism is pharmacologically significant because it suggests reduced risk of hypoglycemia compared to drugs that stimulate insulin release regardless of blood glucose level.
Limitations: In vitro and ex vivo study using rat tissue. Dose extrapolation to human oral consumption of whole fenugreek seed is indirect. The relative contribution of 4-hydroxyisoleucine to the overall hypoglycemic effect of whole fenugreek seed versus fiber and saponin fractions has not been definitively established in humans.
[16]
Dysmenorrhea relief
Double-blind, randomized, placebo-controlled trial evaluating fenugreek seed powder for primary dysmenorrhea.
Findings: Younesy et al. (2014) randomized 101 women with primary dysmenorrhea to fenugreek seed powder (2,500 mg/day for the first 3 days of 2 consecutive menstrual cycles) or placebo. The fenugreek group reported significantly reduced pain severity (by visual analogue scale) and fewer systemic symptoms (nausea, fatigue, headache) compared to placebo. Some subjects in the fenugreek group were able to reduce their use of rescue analgesics.
Limitations: Single study requiring replication. Relatively small sample size. Short intervention period (2 menstrual cycles). Self-reported pain outcomes. The mechanism of analgesic effect is not established.
[17]
Preparations & Dosage
Decoction
Strength: 1-2 teaspoons (3-6 g) crushed seed per 250 mL water
Add 1-2 teaspoons (approximately 3-6 g) of lightly crushed or ground fenugreek seeds to 250 mL cold water. Bring to a boil, reduce heat, and simmer gently for 10-15 minutes. Strain. The resulting decoction will be somewhat bitter and mucilaginous.
6 g of crushed seed per day (Commission E; EMA), equivalent to 1-2 cups of decoction taken in divided doses before meals
2-3 times daily, taken 15-30 minutes before meals for appetite stimulation and glycemic effects
For appetite stimulation: 1-2 weeks (EMA recommends medical consultation if symptoms persist beyond 2 weeks). For metabolic support: long-term use under practitioner guidance.
Not recommended for children under 12 without practitioner guidance due to insufficient safety data
Decoction is the preferred preparation for internal use in traditional herbalism as it efficiently extracts both the mucilaginous galactomannan fiber and the steroidal saponins. The bitterness can be moderated with honey or combined with pleasant-tasting herbs (cinnamon, fennel). Pre-soaking seeds overnight in cold water before decocting increases mucilage extraction.
powdered seed (capsule or direct)
Strength: Whole or defatted seed powder; various standardized extract strengths available commercially
Ground fenugreek seed powder taken directly mixed with water, incorporated into food, or filled into capsules. For clinical glycemic effects, defatted seed powder has been used in most trials.
5-30 g/day of seed powder in divided doses (based on clinical trial ranges). Most commonly studied doses: 5-10 g/day for type 2 diabetes adjunctive support. For galactagogue effect: 1,725-3,500 mg 3 times daily (capsule form). Commission E: 6 g/day total.
2-3 divided doses per day, taken with meals or 15-30 minutes before meals
For glycemic support: long-term use under practitioner monitoring. For lactation support: short-term until lactation is established (typically 1-4 weeks).
Not recommended without practitioner guidance
Powdered seed is the preparation used in most clinical trials and is the most practical form for achieving the doses studied for metabolic effects. Defatted seed powder (used by Sharma et al. 1990 and others) removes the lipid fraction and concentrates the fiber, saponin, and amino acid constituents. Commercial capsules typically contain 500-610 mg of fenugreek seed powder or extract per capsule.
Tincture
Strength: 1:5 dried seed in 45% ethanol (BHP specification)
Macerate dried, crushed fenugreek seeds in 45% ethanol at a ratio of 1:5 for 2-4 weeks. Press and filter.
2-5 mL of 1:5 tincture (in 45% ethanol), 3 times daily
3 times daily before meals
2-4 weeks, then reassess
Not recommended for children under 12
Tincture extracts the alkaloids (trigonelline), flavonoids, and steroidal saponins but does not efficiently extract the mucilaginous galactomannan fiber, which requires an aqueous medium. Therefore, the tincture form may not provide the full spectrum of metabolic benefits (fiber-mediated glucose and lipid effects) and is more suited to appetite stimulation and bitter tonic applications.
poultice (cataplasm)
Strength: 50 g powdered seed per 250 mL hot water (Commission E specification)
Mix 50 g of powdered fenugreek seed with approximately 250 mL of hot water to form a thick, spreadable paste. Allow to cool to a comfortably warm temperature. Apply directly to the affected area or spread on a cloth and apply. Cover with a clean bandage. Replace every 2-4 hours.
50 g powdered seed per application (Commission E)
Apply fresh poultice 2-3 times daily
Until inflammation resolves; discontinue if skin irritation develops
Suitable for external use on children with appropriate temperature caution
The poultice is the Commission E-approved form for external treatment of local inflammation. The mucilaginous paste draws, soothes, and reduces inflammation in boils, abscesses, cellulitis, and superficial wounds. The EMA monograph notes that repeated external applications may result in undesirable skin reactions in sensitive individuals. Traditional application also includes use with vinegar (Dioscorides).
soaked seed (whole)
Strength: 10-15 g whole seed in 250 mL water
Soak 1-2 tablespoons (approximately 10-15 g) of whole fenugreek seeds in 250 mL of water overnight (8-12 hours). In the morning, drink the mucilaginous water and consume the softened seeds. Alternatively, soak in hot water for 1-2 hours.
10-15 g whole seeds soaked overnight, consumed daily including the soaking liquid
Once daily, typically in the morning before breakfast
Ongoing for metabolic support
Not recommended for children under 12
This simple, traditional preparation is widely used in South Asian and Middle Eastern practice. Soaking maximizes mucilage extraction and softens the hard seed coat for easier consumption. Kassaian et al. (2009) noted that fenugreek seeds soaked in hot water produced greater reductions in blood sugar and triglycerides than seeds mixed with yogurt, suggesting that aqueous extraction improves bioavailability of the active mucilaginous and saponin fractions.
Safety & Interactions
Class 2b
Not to be used during lactation (AHPA Botanical Safety Handbook)
Contraindications
AHPA Botanical Safety Handbook classifies fenugreek as Class 2b: 'Not to be used during pregnancy.' Fenugreek has documented uterotonic and emmenagogue properties. Steroidal saponins (diosgenin) may stimulate uterine contractions. Animal studies have shown oxytocic activity. Traditional use as an aid to induce labor further supports this concern. Contraindicated during pregnancy at therapeutic doses. Note: Culinary quantities of fenugreek as a spice are generally considered safe in pregnancy, but concentrated supplemental or therapeutic doses should be avoided.
Cross-reactive allergic reactions may occur in individuals with known allergy to peanuts, chickpeas, soybeans, or other legumes (all Fabaceae). Cases of allergic rhinitis, asthma exacerbation, and anaphylaxis have been reported rarely after fenugreek exposure. Occupational asthma has been documented in spice workers handling fenugreek powder.
Drug Interactions
| Drug / Class | Severity | Mechanism |
|---|---|---|
| Insulin and oral hypoglycemic agents (metformin, sulfonylureas, thiazolidinediones) (Antidiabetic medications) | moderate | Fenugreek's hypoglycemic effects (via galactomannan fiber slowing glucose absorption, 4-hydroxyisoleucine stimulating insulin secretion, and saponin-mediated alpha-glucosidase inhibition) may be additive with conventional hypoglycemic medications, increasing the risk of hypoglycemia. |
| Warfarin and other coumarin anticoagulants (Anticoagulants) | moderate | Fenugreek contains coumarins (scopoletin) and has demonstrated in vitro anticoagulant activity. A published case report (Lambert & Cormier, 2001) documented elevated INR in a patient taking warfarin concurrently with a product containing boldo and fenugreek. |
| Medications absorbed orally (general absorption interaction) (Various oral medications) | moderate | The high mucilaginous fiber content of fenugreek may physically impede or delay the absorption of concomitantly administered oral medications by forming a viscous gel in the gastrointestinal tract. |
Pregnancy & Lactation
Pregnancy
unsafe
Lactation
likely safe
PREGNANCY: Contraindicated at therapeutic doses during pregnancy (AHPA Class 2b). Fenugreek has traditional use as an aid to induce labor and has documented uterotonic and emmenagogue properties. Steroidal saponins may stimulate uterine contractions. Animal studies have demonstrated oxytocic activity. Culinary quantities as a spice condiment are generally considered safe, but concentrated therapeutic doses (capsules, tinctures, decoctions at medicinal dosage) should be avoided throughout pregnancy. LACTATION: Widely used as a galactagogue during breastfeeding and considered likely safe for this purpose. LactMed (NCBI) states that fenugreek is 'sometimes used to increase milk supply during breastfeeding' and notes that maternal doses of up to 6 g daily have been used without reported adverse effects in nursing infants. However, sotolone transfers into breast milk and can cause a maple syrup odor in the infant's urine, which must be distinguished from MSUD. Rarely, infants may develop loose stools. Monitor infant for any unusual symptoms. Fenugreek should be discontinued if it exacerbates maternal asthma or causes allergic symptoms.
Adverse Effects
References
Monograph Sources
- [1] Blumenthal, M., Busse, W.R., Goldberg, A., et al.. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council / Integrative Medicine Communications (1998) . ISBN: 978-0965555500
- [2] World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 3 — Semen Trigonellae Foenugraeci. World Health Organization, Geneva (2007) . ISBN: 978-9241547024
- [3] Committee on Herbal Medicinal Products (HMPC). European Union herbal monograph on Trigonella foenum-graecum L., semen (Revision 1). European Medicines Agency (2018)
- [4] Hoffmann, D.. Medical Herbalism: The Science and Practice of Herbal Medicine. Healing Arts Press (2003) . ISBN: 978-0892817498
- [5] Mills, S., Bone, K.. Principles and Practice of Phytotherapy: Modern Herbal Medicine (2nd edition). Churchill Livingstone / Elsevier (2013) . ISBN: 978-0443069925
- [6] Gardner, Z., McGuffin, M. (eds.). American Herbal Products Association's Botanical Safety Handbook (2nd edition). CRC Press (2013) . ISBN: 978-1466516946
- [7] British Herbal Medicine Association. British Herbal Pharmacopoeia. BHMA (1983)
- [8] Brinker, F.. Herbal Contraindications and Drug Interactions (4th edition). Eclectic Medical Publications (2010) . ISBN: 978-1888483147
Clinical Studies
- [9] Sharma, R.D., Raghuram, T.C., Rao, N.S.. Effect of fenugreek seeds on blood glucose and serum lipids in type I diabetes. European Journal of Clinical Nutrition (1990) ; 44 : 301-306 . PMID: 2194788
- [10] Gupta, A., Gupta, R., Lal, B.. Effect of Trigonella foenum-graecum (fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: a double blind placebo controlled study. Journal of the Association of Physicians of India (2001) ; 49 : 1057-1061 . PMID: 11868855
- [11] Neelakantan, N., Narayanan, M., de Souza, R.J., van Dam, R.M.. Effect of fenugreek (Trigonella foenum-graecum L.) intake on glycemia: a meta-analysis of clinical trials. Nutrition Journal (2014) ; 13 : 7 . DOI: 10.1186/1475-2891-13-7 . PMID: 24438170
- [12] Gong, J., Fang, K., Dong, H., et al.. Effect of fenugreek on hyperglycaemia and hyperlipidemia in diabetes and prediabetes: a meta-analysis. Journal of Ethnopharmacology (2016) ; 194 : 260-268 . DOI: 10.1016/j.jep.2016.08.003 . PMID: 27496582
- [13] Gaddam, A., Galla, C., Thummisetti, S., et al.. Role of fenugreek in the prevention of type 2 diabetes mellitus in prediabetes. Journal of Diabetes and Metabolic Disorders (2015) ; 14 : 74 . DOI: 10.1186/s40200-015-0208-4 . PMID: 26436069
- [14] Foong, S.C., Tan, M.L., Foong, W.C., et al.. Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants. Cochrane Database of Systematic Reviews (2020) ; 5 : CD011505 . DOI: 10.1002/14651858.CD011505.pub2 . PMID: 32390133
- [15] Turkyilmaz, C., Onal, E., Hirfanoglu, I.M., et al.. The effect of galactagogue herbal tea on breast milk production and short-term catch-up of birth weight in the first week of life. Journal of Alternative and Complementary Medicine (2011) ; 17 : 139-142 . DOI: 10.1089/acm.2010.0090 . PMID: 21261516
- [16] Sauvaire, Y., Petit, P., Broca, C., et al.. 4-Hydroxyisoleucine: a novel amino acid potentiator of insulin secretion. Diabetes (1998) ; 47 : 206-210 . DOI: 10.2337/diab.47.2.206 . PMID: 9519714
- [17] Younesy, S., Amiraliakbari, S., Esmaeili, S., et al.. Effects of fenugreek seed on the severity and systemic symptoms of dysmenorrhea. Journal of Reproduction and Infertility (2014) ; 15 : 41-48 . PMID: 24696790
- [18] Sowmya, P., Rajyalakshmi, P.. Hypocholesterolemic effect of germinated fenugreek seeds in human subjects. Plant Foods for Human Nutrition (1999) ; 53 : 359-365 . PMID: 10540987
- [19] Kassaian, N., Azadbakht, L., Forghani, B., Amini, M.. Effect of fenugreek seeds on blood glucose and lipid profiles in type 2 diabetic patients. International Journal for Vitamin and Nutrition Research (2009) ; 79 : 34-39 . DOI: 10.1024/0300-9831.79.1.34 . PMID: 19839001
- [20] Lambert, J.P., Cormier, J.. Potential interaction between warfarin and boldo-fenugreek. Pharmacotherapy (2001) ; 21 : 509-512 . DOI: 10.1592/phco.21.5.509.34495 . PMID: 11310527
Traditional Texts
- [21] Anonymous (ancient Egyptian). Ebers Papyrus (Papyrus Ebers). c. 1550 BCE. University of Leipzig Library. (-1550)
- [22] Dioscorides, Pedanius. De Materia Medica (Peri hyles iatrikes). c. 70 CE. Various modern translations available. (70)
- [23] Bhavamishra. Bhavaprakasha Nighantu (Indian Materia Medica). c. 16th century CE. Chaukhamba Bharati Academy editions. (1550)
- [24] Various Unani scholars. National Formulary of Unani Medicine (NFUM) — Hulba monograph. Central Council for Research in Unani Medicine, Government of India (2006)
Pharmacopeias & Reviews
- [25] European Pharmacopoeia Commission. European Pharmacopoeia — Trigonellae foenugraeci semen (Fenugreek Seed). Council of Europe / EDQM (2023)
- [26] Academy of Breastfeeding Medicine. ABM Clinical Protocol #9: Use of Galactogogues in Initiating or Augmenting Maternal Milk Production (Second Revision 2018). Breastfeeding Medicine (2018) . DOI: 10.1089/bfm.2018.29092.wjb
- [27] National Library of Medicine. Drugs and Lactation Database (LactMed) — Fenugreek. National Center for Biotechnology Information, Bethesda, MD (2024)
Last updated: 2026-03-02 | Status: review
Unlock the Full Materia Medica
This monograph is part of our complete evidence-based herbal reference. Enter your email to get free, unlimited access to all of our monographs.
No spam, ever. Unsubscribe anytime.
You're In!
You now have full access to all of our herbal monographs.